Eukles Asset Management - APPLIED GENETIC TECHNOL CORP ownership

APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 46 filers reported holding APPLIED GENETIC TECHNOL CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Eukles Asset Management ownership history of APPLIED GENETIC TECHNOL CORP
ValueSharesWeighting
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.00%
Other shareholders
APPLIED GENETIC TECHNOL CORP shareholders Q3 2022
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,455,904$7,075,0002.04%
DAFNA Capital Management LLC 1,095,139$5,322,0001.73%
Portolan Capital Management 1,301,075$6,323,0000.72%
Sofinnova Investments, Inc. 825,071$4,010,0000.30%
Ikarian Capital, LLC 545,884$2,654,0000.19%
683 Capital Management, LLC 364,299$1,770,0000.13%
Gyon Technologies Capital Management, LP 18,653$91,0000.07%
ALTRINSIC GLOBAL ADVISORS LLC 336,900$1,637,0000.07%
HighVista Strategies LLC 15,200$74,0000.05%
PURA VIDA INVESTMENTS, LLC 176,411$857,0000.04%
View complete list of APPLIED GENETIC TECHNOL CORP shareholders